|
|
Article: Q&A: SEARCH FOR HIV/AIDS VACCINE PROCEEDS, DESPITE SETBACK.
- Article from:
- Interpress Service
- Article date:
- November 28, 2007
CopyrightCOPYRIGHT 2007 Global Information Network. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
By Nergui Manalsuren
NEW YORK, Nov. 27, 2007 (IPS/GIN) -- One of the world's most promising large-scale HIV vaccine trials was shut down in September after it became clear that the drug was failing to block the virus.
It was a profoundly disappointing moment in the decades-long quest for a vaccine, especially when researchers learned that the vaccine may have even increased the vulnerability of some test volunteers to contracting HIV.
The International AIDS Vaccine Initiative (IAVI), headquartered in New York, is an important player in conducting and promoting vaccine research, through partnerships with more than 40 academic, biotechnology, ...